Terms: = Prostate cancer AND HRAS, K-ras, 3265, ENSG00000174775, HRAS1, RASH1, c-bas/has, P01112, N-ras AND Treatment
29 results:
1. Mechanism of Antitumor Effects of Saffron in Human prostate cancer Cells.
Khan M; Hearn K; Parry C; Rasid M; Brim H; Ashktorab H; Kwabi-Addo B
Nutrients; 2023 Dec; 16(1):. PubMed ID: 38201944
[TBL] [Abstract] [Full Text] [Related]
2. Proteomic analysis of STEAP1 knockdown in human LNCaP prostate cancer cells.
Rocha SM; Santos FM; Socorro S; Passarinha LA; Maia CJ
Biochim Biophys Acta Mol Cell Res; 2023 Oct; 1870(7):119522. PubMed ID: 37315586
[TBL] [Abstract] [Full Text] [Related]
3. Caffeic acid phenethyl ester suppresses EGFR/FAK/Akt signaling, migration, and tumor growth of prostate cancer cells.
Tseng JC; Wang BJ; Wang YP; Kuo YY; Chen JK; Hour TC; Kuo LK; Hsiao PJ; Yeh CC; Kao CL; Shih LJ; Chuu CP
Phytomedicine; 2023 Jul; 116():154860. PubMed ID: 37201366
[TBL] [Abstract] [Full Text] [Related]
4. Post-transcriptional modification of m
Li Y; Zhu S; Chen Y; Ma Q; Kan D; Yu W; Zhang B; Chen X; Wei W; Shao Y; Wang K; Zhang M; Deng S; Niu Y; Shang Z
Cell Death Dis; 2023 Apr; 14(4):289. PubMed ID: 37095108
[TBL] [Abstract] [Full Text] [Related]
5. A new horizon for the old antibacterial drug clofoctol.
Bailly C; Vergoten G
Drug Discov Today; 2021 May; 26(5):1302-1310. PubMed ID: 33581321
[TBL] [Abstract] [Full Text] [Related]
6. 1α,25-Dihydroxyvitamin D
Ben-Eltriki M; Deb S; Guns EST
J Steroid Biochem Mol Biol; 2021 May; 209():105828. PubMed ID: 33493594
[TBL] [Abstract] [Full Text] [Related]
7. CDDO-Me inhibits tumor growth and prevents recurrence of pancreatic ductal adenocarcinoma.
Gao X; Deeb D; Liu Y; Liu P; Zhang Y; Shaw J; Gautam SC
Int J Oncol; 2015 Dec; 47(6):2100-6. PubMed ID: 26497549
[TBL] [Abstract] [Full Text] [Related]
8. The Accomplices of NF-κB Lead to Radioresistance.
Bai M; Ma X; Li X; Wang X; Mei Q; Li X; Wu Z; Han W
Curr Protein Pept Sci; 2015; 16(4):279-94. PubMed ID: 25929862
[TBL] [Abstract] [Full Text] [Related]
9. The Differential Effects of Anti-Diabetic Thiazolidinedione on prostate cancer Progression Are Linked to the TR4 Nuclear Receptor Expression Status.
Lin SJ; Lin CY; Yang DR; Izumi K; Yan E; Niu X; Chang HC; Miyamoto H; Wang N; Li G; Chang C
Neoplasia; 2015 Apr; 17(4):339-47. PubMed ID: 25925376
[TBL] [Abstract] [Full Text] [Related]
10. Humoral Immune Response against Nontargeted Tumor Antigens after treatment with Sipuleucel-T and Its Association with Improved Clinical Outcome.
GuhaThakurta D; Sheikh NA; Fan LQ; Kandadi H; Meagher TC; Hall SJ; Kantoff PW; Higano CS; Small EJ; Gardner TA; Bailey K; Vu T; DeVries T; Whitmore JB; Frohlich MW; Trager JB; Drake CG
Clin Cancer Res; 2015 Aug; 21(16):3619-30. PubMed ID: 25649018
[TBL] [Abstract] [Full Text] [Related]
11. Potentiating effects of GHRH analogs on the response to chemotherapy.
Schally AV; Perez R; Block NL; Rick FG
Cell Cycle; 2015; 14(5):699-704. PubMed ID: 25648497
[TBL] [Abstract] [Full Text] [Related]
12. Effects of zoledronic acid and docetaxel on small GTP-binding proteins in prostate cancer.
Jones RM; Morgan C; Bertelli G
Tumour Biol; 2015 Jun; 36(6):4861-9. PubMed ID: 25631751
[TBL] [Abstract] [Full Text] [Related]
13. Disruption of endothelial adherens junction by invasive breast cancer cells is mediated by reactive oxygen species and is attenuated by AHCC.
Haidari M; Zhang W; Wakame K
Life Sci; 2013 Dec; 93(25-26):994-1003. PubMed ID: 24211779
[TBL] [Abstract] [Full Text] [Related]
14. Mutations in k-ras linked to levels of osteoprotegerin and sensitivity to TRAIL-induced cell death in pancreatic ductal adenocarcinoma cells.
Kanzaki H; Ohtaki A; Merchant FK; Greene MI; Murali R
Exp Mol Pathol; 2013 Apr; 94(2):372-9. PubMed ID: 23219833
[TBL] [Abstract] [Full Text] [Related]
15. Quercetin inhibits invasion, migration and signalling molecules involved in cell survival and proliferation of prostate cancer cell line (PC-3).
Senthilkumar K; Arunkumar R; Elumalai P; Sharmila G; Gunadharini DN; Banudevi S; Krishnamoorthy G; Benson CS; Arunakaran J
Cell Biochem Funct; 2011 Mar; 29(2):87-95. PubMed ID: 21308698
[TBL] [Abstract] [Full Text] [Related]
16. Modulation of E-cadherin expression by k-ras; involvement of DNA methyltransferase-3b.
Kwon O; Jeong SJ; Kim SO; He L; Lee HG; Jang KL; Osada H; Jung M; Kim BY; Ahn JS
Carcinogenesis; 2010 Jul; 31(7):1194-201. PubMed ID: 20375073
[TBL] [Abstract] [Full Text] [Related]
17. CD133 is indicative for a resistance phenotype but does not represent a prognostic marker for survival of non-small cell lung cancer patients.
Salnikov AV; Gladkich J; Moldenhauer G; Volm M; Mattern J; Herr I
Int J Cancer; 2010 Feb; 126(4):950-8. PubMed ID: 19676044
[TBL] [Abstract] [Full Text] [Related]
18. Discovery of a novel proteasome inhibitor selective for cancer cells over non-transformed cells.
Kazi A; Lawrence H; Guida WC; McLaughlin ML; Springett GM; Berndt N; Yip RM; Sebti SM
Cell Cycle; 2009 Jun; 8(12):1940-51. PubMed ID: 19471122
[TBL] [Abstract] [Full Text] [Related]
19. Inactivation of the candidate tumor suppressor par-4 in endometrial cancer.
Moreno-Bueno G; Fernandez-Marcos PJ; Collado M; Tendero MJ; Rodriguez-Pinilla SM; Garcia-Cao I; Hardisson D; Diaz-Meco MT; Moscat J; Serrano M; Palacios J
Cancer Res; 2007 Mar; 67(5):1927-34. PubMed ID: 17332319
[TBL] [Abstract] [Full Text] [Related]
20. MEK1/2 inhibition promotes Taxotere lethality in mammary tumors in vivo.
Yacoub A; Gilfor D; Hawkins W; Park MA; Hanna D; Hagan MP; Curiel DT; Fisher PB; Grant S; Dent P
Cancer Biol Ther; 2006 Oct; 5(10):1332-9. PubMed ID: 16957420
[TBL] [Abstract] [Full Text] [Related]
[Next]